New Releases from NCBI BookshelfMethylphenidate versus placebo for fatigue in patients with advanced cancer: the MePFAC randomised controlled trial.​Methylphenidate versus placebo for fatigue in patients with advanced cancer: the MePFAC randomised controlled trial.

By /

Previous meta-analyses suggested methylphenidate may be effective for cancer-related fatigue.

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Useful Links

NEWREDMARS SKILL AND RESEARCH        FOUNDATION

Registration No: 771800548      Contact Number : +91-8249516996

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.

Scroll to Top